Published in Naunyn Schmiedebergs Arch Pharmacol on December 24, 2016
Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther (1977) 8.46
Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) (2004) 2.74
Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA (2008) 2.56
Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA (2003) 2.30
The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry (2015) 2.27
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther (2008) 1.95
Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry (2001) 1.88
Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des (2009) 1.77
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther (2006) 1.59
Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil. Br J Clin Pharmacol (2001) 1.45
The significance of the nitric oxide in electro-convulsive therapy: a proposed neurophysiological mechanism. Med Hypotheses (2003) 1.40
Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice. Pharmacol Biochem Behav (1999) 1.09
Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract (2009) 1.06
Versatile effects of sildenafil: recent pharmacological applications. Pharmacol Rep (2007) 1.05
Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test. Eur Neuropsychopharmacol (2010) 1.00
Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo. Am J Cancer Res (2015) 0.94
Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci (2000) 0.93
Impact of medical comorbid disease on antidepressant treatment of major depressive disorder. Curr Psychiatry Rep (2004) 0.91
Comorbidity of depression with physical disorders: research and clinical implications. Chonnam Med J (2015) 0.89
Evidence for the involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav Brain Res (2006) 0.89
Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol (2007) 0.89
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes. Annu Rev Sex Res (2002) 0.88
Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical Literature. PLoS One (2015) 0.87
Aggressive behavior increases after termination of chronic sildenafil treatment in mice. Physiol Behav (2005) 0.87
Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression. Urology (2002) 0.87
Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol (2007) 0.87
Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF. Neurobiol Dis (2010) 0.86
Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.85
Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies. J Neural Transm (Vienna) (2007) 0.85
The role of the NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of duloxetine in the forced swimming test. Pharmacol Biochem Behav (2012) 0.82
Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test. Eur J Pharmacol (2016) 0.82
Repeated and chronic administration of Vardenafil or Sildenafil differentially affects emotional and socio-sexual behavior in mice. Behav Brain Res (2013) 0.81
Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice. Pharmacol Biochem Behav (2012) 0.81
Rewarding properties of sildenafil citrate in mice: role of the nitric oxide-cyclic GMP pathway. Psychopharmacology (Berl) (2006) 0.81
Sildenafil citrate for the management of antidepressant-associated erectile dysfunction. J Clin Psychiatry (2003) 0.81
Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review. Respir Med (2014) 0.81
Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol Biochem Behav (2004) 0.80
Screening pulmonary hypertension patients for depression. Int J Clin Pract Suppl (2011) 0.80
Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice. J Neural Transm (Vienna) (2012) 0.80
Sildenafil, a phosphodiesterase type 5 inhibitor, reduces antidepressant-like activity of paroxetine in the forced swim test in mice. Pharmacol Rep (2012) 0.78
Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the activity of two atypical antidepressant drugs, mianserin and tianeptine, in the forced swim test in mice. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.78
The involvement of NMDA receptor/NO/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test. Neurosci Lett (2015) 0.77
Specific aspects of erectile dysfunction in psychiatry. Int J Impot Res (2004) 0.77
Involvement of NMDA receptors and l-arginine/nitric oxide/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test. Brain Res Bull (2016) 0.76
Antidepressant-like activity of sildenafil following acute and subchronic treatment in the forced swim test in mice: effects of restraint stress and monoamine depletion. Metab Brain Dis (2016) 0.76
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice. Metab Brain Dis (2016) 0.76
Antidepressant-like activity of sildenafil following acute and subchronic treatment in the forced swim test in mice: effects of restraint stress and monoamine depletion. Metab Brain Dis (2016) 0.76
Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice. J Neural Transm (Vienna) (2016) 0.75
Traxoprodil augments the antidepressant-like activity of agomelatine but not of mianserin or tianeptine in the forced swim test in mice. Pharmacol Rep (2016) 0.75
Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice. Pharmacol Rep (2015) 0.75